MMSI
Merit Medical Systems, Inc.
Price Chart
Latest Quote
$69.14
+1.87 (+2.77%)
Current Price
| Previous Close | $67.27 |
| Open | $67.45 |
| Day High | $69.48 |
| Day Low | $67.45 |
| Volume | 400,305 |
Stock Information
| Shares Outstanding | 59.65M |
| Total Debt | $821.56M |
| Cash Equivalents | $488.08M |
| Revenue | $1.54B |
| Net Income | $139.34M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $4.12B |
| P/E Ratio | 29.80 |
| EPS (TTM) | $2.32 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.35B |
| Sales | $1.54B |
| Income | $139.34M |
| Book/sh | $27.27 |
| Cash/sh | $8.18 |
| Employees | 8K |
Financial Ratios
| Quick Ratio | 3.30 |
| Current Ratio | 5.08 |
| Debt/Eq | 50.50 |
| EPS Growth TTM | 36.00% |
Returns & Margins
| ROA | 4.72% |
| ROE | 9.12% |
| Gross Margin | 48.69% |
| Operating Margin | 11.52% |
| Profit Margin | 9.03% |
Ownership
| Insider Ownership | 2.48% |
| Institutional Ownership | 104.56% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 15.72 |
| PEG | 1.41 |
| P/S | 2.67 |
| P/B | 2.54 |
Analyst Data
| Recommendation | none |
| Target Price | $89.55 |
Technical Indicators
| SMA20 | $65.22 |
| SMA50 | $65.21 |
| SMA200 | $77.30 |
| RSI | 75.31 |
| ATR | 2.1586 |
| Shares Float | 58.18M |
| Short Float | 6.68% |
| Short Ratio | 3.17 |
| Volatility | 0.53 |
| Rel Volume | 0.52 |
Performance History
| Week | +2.15% |
| Month | +7.74% |
| Quarter | +2.35% |
| 6 Months | -21.17% |
| YTD | -20.03% |
| Year | -25.11% |
| 3 Years | -16.98% |
| 5 Years | +12.05% |
| 10 Years | +268.92% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $69.14 | 400,305 |
| 2026-06-23 | $67.27 | 825,300 |
| 2026-06-22 | $66.50 | 605,900 |
| 2026-06-18 | $67.22 | 1,182,100 |
| 2026-06-17 | $65.24 | 840,900 |
| 2026-06-16 | $67.68 | 880,300 |
| 2026-06-15 | $66.94 | 545,800 |
| 2026-06-12 | $66.53 | 514,900 |
| 2026-06-11 | $66.89 | 661,700 |
| 2026-06-10 | $66.99 | 940,000 |
| 2026-06-09 | $67.51 | 946,300 |
| 2026-06-08 | $66.03 | 1,176,400 |
| 2026-06-05 | $64.48 | 710,900 |
| 2026-06-04 | $63.04 | 648,300 |
| 2026-06-03 | $60.65 | 663,400 |
| 2026-06-02 | $60.89 | 795,700 |
| 2026-06-01 | $62.05 | 715,200 |
| 2026-05-29 | $63.06 | 880,200 |
| 2026-05-28 | $63.75 | 634,100 |
| 2026-05-27 | $62.52 | 919,500 |
| 2026-05-26 | $64.52 | 713,300 |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
đ° Latest News
3 Healthcare Stocks with Open Questions
StockStory âĸ 2026-06-12T09:58:56Z
Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Zacks âĸ 2026-06-08T16:15:00Z
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Zacks âĸ 2026-06-08T15:52:00Z
3 of Wall Streetâs Favorite Stocks That Fall Short
StockStory âĸ 2026-06-04T23:57:30Z
Is Merit Medical Systems (MMSI) Attractive After A 34% One Year Share Price Slide
Simply Wall St. âĸ 2026-06-02T21:18:04Z
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Zacks âĸ 2026-06-02T13:40:03Z
2 Reasons to Avoid MMSI and 1 Stock to Buy Instead
StockStory âĸ 2026-05-26T13:19:28Z
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
StockStory âĸ 2026-05-19T11:00:55Z
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
Motley Fool âĸ 2026-05-17T15:33:01Z
1 Profitable Stock to Own for Decades and 2 We Avoid
StockStory âĸ 2026-05-15T15:48:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $777,636,000 | $713,181,000 | $673,494,000 | $631,882,000 |
| Cost Of Revenue | $777,636,000 | $713,181,000 | $673,494,000 | $631,882,000 |
| Total Revenue | $1,515,906,000 | $1,356,514,000 | $1,257,366,000 | $1,150,981,000 |
| Operating Revenue | $1,515,906,000 | $1,356,514,000 | $1,257,366,000 | $1,150,981,000 |
| Expenses | ||||
| Interest Expense | $26,461,000 | $31,219,000 | $15,511,000 | $6,339,000 |
| Total Expenses | $1,330,202,000 | $1,200,378,000 | $1,129,898,000 | $1,049,917,000 |
| Other Income Expense | $-3,376,000 | $-1,154,000 | $-2,324,000 | $-12,535,000 |
| Other Non Operating Income Expenses | $-2,392,000 | $-711,000 | $1,200,000 | $966,000 |
| Net Non Operating Interest Income Expense | $-11,391,000 | $-4,989,000 | $-13,055,000 | $-5,900,000 |
| Interest Expense Non Operating | $26,461,000 | $31,219,000 | $15,511,000 | $6,339,000 |
| Operating Expense | $552,566,000 | $487,197,000 | $456,404,000 | $418,035,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Net Interest Income | $-11,391,000 | $-4,989,000 | $-13,055,000 | $-5,900,000 |
| Interest Income | $15,070,000 | $26,230,000 | $2,456,000 | $439,000 |
| Normalized Income | $129,228,968 | $120,712,286 | $97,378,208 | $86,693,902 |
| Net Income From Continuing And Discontinued Operation | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Total Operating Income As Reported | $184,720,000 | $155,693,000 | $123,944,000 | $87,563,000 |
| Net Income Common Stockholders | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Net Income | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Net Income Including Noncontrolling Interests | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Net Income Continuous Operations | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Pretax Income | $170,937,000 | $149,993,000 | $112,089,000 | $82,629,000 |
| Special Income Charges | $-984,000 | $-443,000 | $-3,524,000 | $-13,501,000 |
| Interest Income Non Operating | $15,070,000 | $26,230,000 | $2,456,000 | $439,000 |
| Operating Income | $185,704,000 | $156,136,000 | $127,468,000 | $101,064,000 |
| Gross Profit | $738,270,000 | $643,333,000 | $583,872,000 | $519,099,000 |
| Per Share | ||||
| Diluted EPS | $2.13 | $2.03 | $1.62 | $1.29 |
| Basic EPS | $2.17 | $2.07 | $1.64 | $1.31 |
| Other | ||||
| Tax Effect Of Unusual Items | $-244,032 | $-87,714 | $-556,792 | $-1,323,098 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $333,031,000 | $296,387,000 | $232,416,000 | $194,667,000 |
| Total Unusual Items | $-984,000 | $-443,000 | $-3,524,000 | $-13,501,000 |
| Total Unusual Items Excluding Goodwill | $-984,000 | $-443,000 | $-3,524,000 | $-13,501,000 |
| Reconciled Depreciation | $134,649,000 | $114,732,000 | $101,292,000 | $92,198,000 |
| EBITDA (Bullshit earnings) | $332,047,000 | $295,944,000 | $228,892,000 | $181,166,000 |
| EBIT | $197,398,000 | $181,212,000 | $127,600,000 | $88,968,000 |
| Diluted Average Shares | $60,460,000 | $59,365,000 | $58,356,000 | $57,671,000 |
| Basic Average Shares | $59,158,000 | $58,218,000 | $57,593,000 | $56,806,000 |
| Diluted NI Availto Com Stockholders | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Tax Provision | $42,448,000 | $29,636,000 | $17,678,000 | $8,113,000 |
| Impairment Of Capital Assets | $0 | $0 | $270,000 | $2,219,000 |
| Restructuring And Mergern Acquisition | $984,000 | $443,000 | $1,704,000 | $4,611,000 |
| Research And Development | $97,352,000 | $87,466,000 | $82,728,000 | $75,510,000 |
| Selling General And Administration | $455,214,000 | $399,731,000 | $373,676,000 | $342,525,000 |
| Other Special Charges | - | - | $1,550,000 | $6,671,000 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $539,812,000 | $417,583,000 | $493,877,000 | $508,704,000 |
| Total Assets | $2,685,922,000 | $2,418,603,000 | $2,325,244,000 | $1,663,966,000 |
| Total Non Current Assets | $1,645,768,000 | $1,494,829,000 | $1,216,774,000 | $1,134,882,000 |
| Other Non Current Assets | $10,418,000 | $12,365,000 | $14,182,000 | $10,612,000 |
| Non Current Deferred Assets | $29,863,000 | $36,760,000 | $25,597,000 | $22,366,000 |
| Non Current Deferred Taxes Assets | $7,049,000 | $16,044,000 | $7,288,000 | $6,599,000 |
| Non Current Note Receivables | $16,252,000 | $9,423,000 | $3,241,000 | $2,397,000 |
| Goodwill And Other Intangible Assets | $1,044,491,000 | $961,776,000 | $708,123,000 | $635,693,000 |
| Other Intangible Assets | $537,654,000 | $498,265,000 | $325,883,000 | $275,872,000 |
| Current Assets | $1,040,154,000 | $923,774,000 | $1,108,470,000 | $529,084,000 |
| Other Current Assets | $31,493,000 | $28,544,000 | $24,286,000 | $22,324,000 |
| Prepaid Assets | $4,941,000 | $3,286,000 | $4,016,000 | $3,913,000 |
| Inventory | $333,705,000 | $306,063,000 | $303,871,000 | $265,991,000 |
| Receivables | $223,611,000 | $209,166,000 | $189,261,000 | $178,448,000 |
| Other Receivables | $17,773,000 | $16,588,000 | $10,517,000 | $12,992,000 |
| Taxes Receivable | $2,128,000 | $2,335,000 | $859,000 | $779,000 |
| Accounts Receivable | $203,710,000 | $190,243,000 | $177,885,000 | $164,677,000 |
| Allowance For Doubtful Accounts Receivable | $-10,136,000 | $-9,729,000 | $-9,023,000 | $-8,423,000 |
| Gross Accounts Receivable | $213,846,000 | $199,972,000 | $186,908,000 | $173,100,000 |
| Cash Cash Equivalents And Short Term Investments | $446,404,000 | $376,715,000 | $587,036,000 | $58,408,000 |
| Cash And Cash Equivalents | $446,404,000 | $376,715,000 | $587,036,000 | $58,408,000 |
| Debt | ||||
| Net Debt | $287,634,000 | $352,836,000 | $235,977,000 | $139,601,000 |
| Total Debt | $821,572,000 | $794,665,000 | $891,359,000 | $268,750,000 |
| Long Term Debt And Capital Lease Obligation | $810,696,000 | $784,334,000 | $879,272,000 | $246,495,000 |
| Long Term Debt | $734,038,000 | $729,551,000 | $823,013,000 | $186,759,000 |
| Current Debt And Capital Lease Obligation | $10,876,000 | $10,331,000 | $12,087,000 | $22,255,000 |
| Current Debt | - | - | - | $11,250,000 |
| Other Current Borrowings | - | - | - | $11,250,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,101,619,000 | $1,039,244,000 | $1,123,244,000 | $519,569,000 |
| Total Non Current Liabilities Net Minority Interest | $861,855,000 | $822,842,000 | $919,680,000 | $298,924,000 |
| Other Non Current Liabilities | $12,554,000 | $17,569,000 | $15,742,000 | $16,648,000 |
| Tradeand Other Payables Non Current | $17,542,000 | $19,197,000 | $17,514,000 | $15,611,000 |
| Non Current Deferred Liabilities | $21,063,000 | $1,742,000 | $7,152,000 | $20,170,000 |
| Non Current Deferred Taxes Liabilities | $19,665,000 | $240,000 | $5,547,000 | $18,462,000 |
| Current Liabilities | $239,764,000 | $216,402,000 | $203,564,000 | $220,645,000 |
| Current Deferred Liabilities | $247,000 | $158,000 | $285,000 | $165,000 |
| Payables And Accrued Expenses | $228,641,000 | $205,913,000 | $191,192,000 | $198,225,000 |
| Interest Payable | $9,344,000 | $9,531,000 | $1,556,000 | - |
| Payables | $81,677,000 | $83,772,000 | $82,035,000 | $86,126,000 |
| Other Payable | $12,275,000 | $11,778,000 | $11,005,000 | $10,925,000 |
| Total Tax Payable | $8,851,000 | $3,492,000 | $5,086,000 | $6,697,000 |
| Income Tax Payable | $8,851,000 | $3,492,000 | $5,086,000 | $6,697,000 |
| Accounts Payable | $60,551,000 | $68,502,000 | $65,944,000 | $68,504,000 |
| Equity | ||||
| Common Stock Equity | $1,584,303,000 | $1,379,359,000 | $1,202,000,000 | $1,144,397,000 |
| Total Equity Gross Minority Interest | $1,584,303,000 | $1,379,359,000 | $1,202,000,000 | $1,144,397,000 |
| Stockholders Equity | $1,584,303,000 | $1,379,359,000 | $1,202,000,000 | $1,144,397,000 |
| Gains Losses Not Affecting Retained Earnings | $-3,636,000 | $-19,401,000 | $-11,334,000 | $-11,550,000 |
| Other Equity Adjustments | $-3,636,000 | $-19,401,000 | $-11,334,000 | $-11,550,000 |
| Retained Earnings | $824,030,000 | $695,541,000 | $575,184,000 | $480,773,000 |
| Other | ||||
| Ordinary Shares Number | $59,424,000 | $58,743,000 | $57,858,000 | $57,306,000 |
| Share Issued | $59,424,000 | $58,743,000 | $57,858,000 | $57,306,000 |
| Tangible Book Value | $539,812,000 | $417,583,000 | $493,877,000 | $508,704,000 |
| Invested Capital | $2,318,341,000 | $2,108,910,000 | $2,025,013,000 | $1,342,406,000 |
| Working Capital | $800,390,000 | $707,372,000 | $904,906,000 | $308,439,000 |
| Capital Lease Obligations | $87,534,000 | $65,114,000 | $68,346,000 | $70,741,000 |
| Total Capitalization | $2,318,341,000 | $2,108,910,000 | $2,025,013,000 | $1,331,156,000 |
| Capital Stock | $763,909,000 | $703,219,000 | $638,150,000 | $675,174,000 |
| Common Stock | $763,909,000 | $703,219,000 | $638,150,000 | $675,174,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $1,398,000 | $1,502,000 | $1,605,000 | $1,708,000 |
| Long Term Capital Lease Obligation | $76,658,000 | $54,783,000 | $56,259,000 | $59,736,000 |
| Current Capital Lease Obligation | $10,876,000 | $10,331,000 | $12,087,000 | $11,005,000 |
| Current Accrued Expenses | $146,964,000 | $122,141,000 | $109,157,000 | $112,099,000 |
| Investments And Advances | $28,743,000 | $22,832,000 | $19,061,000 | $15,576,000 |
| Other Investments | $28,743,000 | $22,832,000 | $19,061,000 | $15,576,000 |
| Goodwill | $506,837,000 | $463,511,000 | $382,240,000 | $359,821,000 |
| Net PPE | $516,001,000 | $451,673,000 | $446,570,000 | $448,238,000 |
| Accumulated Depreciation | $-376,445,000 | $-351,605,000 | $-329,036,000 | $-303,271,000 |
| Gross PPE | $892,446,000 | $803,278,000 | $775,606,000 | $751,509,000 |
| Leases | $65,236,000 | $58,770,000 | $53,638,000 | $49,673,000 |
| Construction In Progress | $82,939,000 | $58,673,000 | $61,439,000 | $61,269,000 |
| Other Properties | $452,877,000 | $406,372,000 | $379,977,000 | $364,351,000 |
| Machinery Furniture Equipment | $60,883,000 | $61,321,000 | $63,044,000 | $61,128,000 |
| Buildings And Improvements | $200,046,000 | $192,296,000 | $191,491,000 | $189,148,000 |
| Land And Improvements | $30,465,000 | $25,846,000 | $26,017,000 | $25,940,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $190,616,000 | $168,437,000 | $158,893,000 | $147,051,000 |
| Work In Process | $32,391,000 | $27,114,000 | $25,420,000 | $29,534,000 |
| Raw Materials | $110,698,000 | $110,512,000 | $119,558,000 | $89,406,000 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $212,535,000 | $182,756,000 | $108,450,000 | $66,087,000 |
| Operating Activities | ||||
| Operating Cash Flow | $297,371,000 | $220,799,000 | $145,151,000 | $114,291,000 |
| Cash Flow From Continuing Operating Activities | $297,371,000 | $220,799,000 | $145,151,000 | $114,291,000 |
| Operating Gains Losses | $2,053,000 | $1,490,000 | $5,407,000 | $1,797,000 |
| Investing Activities | ||||
| Capital Expenditure | $-84,836,000 | $-38,043,000 | $-36,701,000 | $-48,204,000 |
| Investing Cash Flow | $-247,386,000 | $-368,653,000 | $-175,347,000 | $-57,397,000 |
| Cash Flow From Continuing Investing Activities | $-247,386,000 | $-368,653,000 | $-175,347,000 | $-57,397,000 |
| Net Other Investing Changes | $-17,781,000 | $-10,428,000 | $-4,123,000 | $-1,412,000 |
| Capital Expenditure Reported | $-84,836,000 | $-38,043,000 | $-36,701,000 | $-48,204,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $28,213,000 | $40,908,000 | $15,584,000 | $20,070,000 |
| Financing Cash Flow | $15,999,000 | $-60,008,000 | $559,266,000 | $-60,260,000 |
| Cash Flow From Continuing Financing Activities | $15,999,000 | $-60,008,000 | $559,266,000 | $-60,260,000 |
| Net Other Financing Charges | $-12,214,000 | $-1,853,000 | $-75,897,000 | $-35,392,000 |
| Net Common Stock Issuance | $28,213,000 | $40,908,000 | $15,584,000 | $20,070,000 |
| Common Stock Issuance | $28,213,000 | $40,908,000 | $15,584,000 | $20,070,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-99,063,000 | $-579,624,000 | $-260,143,000 |
| Issuance Of Debt | $0 | $0 | $1,199,203,000 | $215,205,000 |
| Interest Paid Supplemental Data | $20,991,000 | $23,244,000 | $14,051,000 | $6,258,000 |
| Income Tax Paid Supplemental Data | $31,392,000 | $45,047,000 | $31,534,000 | $17,092,000 |
| End Cash Position | $448,549,000 | $378,767,000 | $589,144,000 | $60,558,000 |
| Beginning Cash Position | $378,767,000 | $589,144,000 | $60,558,000 | $67,750,000 |
| Effect Of Exchange Rate Changes | $3,798,000 | $-2,515,000 | $-484,000 | $-3,826,000 |
| Changes In Cash | $65,984,000 | $-207,862,000 | $529,070,000 | $-3,366,000 |
| Net Issuance Payments Of Debt | $0 | $-99,063,000 | $619,579,000 | $-44,938,000 |
| Net Long Term Debt Issuance | $0 | $-99,063,000 | $619,579,000 | $-44,938,000 |
| Long Term Debt Payments | $0 | $-99,063,000 | $-579,624,000 | $-260,143,000 |
| Long Term Debt Issuance | $0 | $0 | $1,199,203,000 | $215,205,000 |
| Net Business Purchase And Sale | $-144,769,000 | $-320,182,000 | $-134,523,000 | $-7,846,000 |
| Purchase Of Business | $-144,769,000 | $-320,182,000 | $-134,523,000 | $-7,846,000 |
| Change In Working Capital | $-23,344,000 | $-36,945,000 | $-70,022,000 | $-71,398,000 |
| Change In Other Working Capital | $-1,655,000 | $2,030,000 | $1,903,000 | $-2,848,000 |
| Change In Other Current Liabilities | $-12,034,000 | $-10,948,000 | $-14,022,000 | $-10,894,000 |
| Change In Other Current Assets | $-1,697,000 | $-6,066,000 | $-5,976,000 | $657,000 |
| Change In Payables And Accrued Expense | $20,503,000 | $5,616,000 | $-11,466,000 | $803,000 |
| Change In Accrued Expense | $14,262,000 | $9,715,000 | $-2,484,000 | $-16,379,000 |
| Change In Payable | $6,241,000 | $-4,099,000 | $-8,982,000 | $17,182,000 |
| Change In Account Payable | $1,011,000 | $-2,314,000 | $-7,297,000 | $12,661,000 |
| Change In Tax Payable | $5,230,000 | $-1,785,000 | $-1,685,000 | $4,521,000 |
| Change In Income Tax Payable | $5,230,000 | $-1,785,000 | $-1,685,000 | $4,521,000 |
| Change In Prepaid Assets | $-4,132,000 | $-3,586,000 | $1,189,000 | $-2,177,000 |
| Change In Inventory | $-21,602,000 | $-2,287,000 | $-32,105,000 | $-47,929,000 |
| Change In Receivables | $-2,727,000 | $-21,704,000 | $-9,545,000 | $-9,010,000 |
| Changes In Account Receivables | $-7,341,000 | $-13,686,000 | $-11,916,000 | $-15,116,000 |
| Other Non Cash Items | $6,537,000 | $7,109,000 | $4,867,000 | $11,779,000 |
| Stock Based Compensation | $43,460,000 | $28,473,000 | $21,333,000 | $18,042,000 |
| Asset Impairment Charge | $313,000 | $456,000 | $506,000 | $2,281,000 |
| Deferred Tax | $5,214,000 | $-14,873,000 | $-12,643,000 | $-14,924,000 |
| Deferred Income Tax | $5,214,000 | $-14,873,000 | $-12,643,000 | $-14,924,000 |
| Depreciation Amortization Depletion | $134,649,000 | $114,732,000 | $101,292,000 | $92,198,000 |
| Depreciation And Amortization | $134,649,000 | $114,732,000 | $101,292,000 | $92,198,000 |
| Depreciation | $134,649,000 | $114,732,000 | $101,292,000 | $92,198,000 |
| Gain Loss On Sale Of PPE | $2,302,000 | $1,490,000 | $5,838,000 | $380,000 |
| Gain Loss On Sale Of Business | $-249,000 | $0 | $-431,000 | $1,417,000 |
| Net Income From Continuing Operations | $128,489,000 | $120,357,000 | $94,411,000 | $74,516,000 |
| Sale Of Business | - | $0 | $431,000 | - |
| Net PPE Purchase And Sale | - | $5,000 | $201,000 | $65,000 |
| Sale Of PPE | - | $5,000 | $201,000 | $65,000 |
Fetched: 2026-06-21